{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:06:16Z","timestamp":1793120776459,"version":"4.5.0"},"reference-count":92,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: The varicella-zoster virus is a highly contagious human herpesvirus that primarily causes varicella (chickenpox) as an initial infection, targeting T cells, neurons, as well as skin cells, and can later reactivate to cause herpes zoster (shingles). Following reactivation, the varicella-zoster virus infection can lead to severe complications, the most common of which is postherpetic neuralgia. Risk factors include aging, immunosuppression, chronic diseases such as diabetes, cardiovascular disorders, respiratory conditions, and others. Objective: In this article, we present an analysis of factors increasing the risk of herpes zoster occurrence, complications, and recurrences (in particular in immunocompromised patients).<\/jats:p>","DOI":"10.3390\/diseases13030071","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T06:15:33Z","timestamp":1740550533000},"page":"71","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients"],"prefix":"10.3390","volume":"13","author":[{"given":"Micha\u0142","family":"Oleszko","sequence":"first","affiliation":[{"name":"College of Medical Sciences, University of Rzesz\u00f3w, 35-315 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-472X","authenticated-orcid":false,"given":"Pawe\u0142","family":"Zapolnik","sequence":"additional","affiliation":[{"name":"College of Medical Sciences, University of Rzesz\u00f3w, 35-315 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Kmiecik","sequence":"additional","affiliation":[{"name":"St. Louis Provincial Specialist Children\u2019s Hospital, 31-503 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Czajka","sequence":"additional","affiliation":[{"name":"College of Medical Sciences, University of Rzesz\u00f3w, 35-315 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rani, N.A., Moin, A.T., Patil, R., Robin, T.B., Zubair, T., Nawal, N., Sami, R.S., Morshed, M., Zhai, J., and Xue, M. (2023). Designing a polyvalent vaccine targeting multiple strains of varicella zoster virus using integrated bioinformatics approaches. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1291868"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tayyar, R., and Ho, D. (2023). Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients. Viruses, 15.","DOI":"10.3390\/v15020439"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ishihara, R., Watanabe, R., Shiomi, M., Katsushima, M., Fukumoto, K., Yamada, S., Okano, T., and Hashimoto, M. (2024). Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Biomolecules, 14.","DOI":"10.3390\/biom14070739"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11806","DOI":"10.1128\/JVI.00466-06","article-title":"ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo","volume":"80","author":"Sommer","year":"2006","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1128\/JVI.79.20.12921-12933.2005","article-title":"T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection","volume":"79","author":"Schaap","year":"2005","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Patil, A., Goldust, M., and Wollina, U. (2022). Herpes zoster: A Review of Clinical Manifestations and Management. Viruses, 14.","DOI":"10.3390\/v14020192"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1128\/JVI.76.22.11425-11433.2002","article-title":"Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory, and skin homing markers","volume":"76","author":"Ku","year":"2002","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s40588-019-00119-2","article-title":"Insights into the pathogenesis of varicella viruses","volume":"6","author":"Sorel","year":"2019","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1017\/S0950268821001102","article-title":"Communicability of varicella before rash onset: A literature review","volume":"149","author":"Marin","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"ref_11","first-page":"841","article-title":"Zagro\u017cenie p\u00f3\u0142pa\u015bcem i jego powik\u0142aniami w Polsce w zale\u017cno\u015bci od wieku","volume":"69","author":"Albrecht","year":"2015","journal-title":"Przegl\u0105d Epidemiol. Epidemiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e0122721","DOI":"10.1128\/JVI.01227-21","article-title":"Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons","volume":"95","author":"Rajbhandari","year":"2021","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/infdis\/jiz653","article-title":"How Little We Know Herpes Zoster","volume":"222","author":"Harpaz","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Govaerts, J., Van Breedam, E., De Beuckeleer, S., Goethals, C., D\u2019Incal, C.P., Di Stefano, J., Van Calster, S., Buyle-Huybrecht, T., Boeren, M., and De Reu, H. (2024). Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1458967"},{"key":"ref_15","first-page":"217","article-title":"Presentation and management of herpes zoster (shingles) in the geriatric population","volume":"38","author":"Cohen","year":"2013","journal-title":"Pharm. Ther."},{"key":"ref_16","unstructured":"Centers for Disease Control and Prevention (2025, February 01). Shingles (Herpes Zoster)\u2014Clinical Overview, Available online: https:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview\/index.html."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/S2666-7568(22)00039-3","article-title":"Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: A systematic review and meta-analysis","volume":"3","author":"Mbinta","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: Towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.37201\/req\/004.2023","article-title":"Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper","volume":"36","year":"2023","journal-title":"Rev. Esp. Quim."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ku, H.C., Wu, Y.L., Yip, H.T., Hsieh, C.Y., Li, C.Y., Ou, H.T., Chen, Y.C., and Ko, N.Y. (2023). Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: A nested case-control study. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08628-8"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaad.2021.06.870","article-title":"Diminishing the risk of herpes zoster recurrence","volume":"85","author":"Heymann","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kennedy, P.G.E. (2023). The Spectrum of Neurological Manifestations of Varicella\u2013Zoster Virus Reactivation. Viruses, 15.","DOI":"10.3390\/v15081663"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","article-title":"Increased risk of stroke after a herpes zoster attack: A population-based follow-up study","volume":"40","author":"Kang","year":"2009","journal-title":"Stroke"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Katsambas, A.D., Lotti, T.M., Dessinioti, C., and D\u2019Erme, A.M. (2023). Herpes Zoster. European Handbook of Dermatological Treatment, Springer.","DOI":"10.1007\/978-3-031-15130-9"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.331.7509.147","article-title":"Managing ophthalmic herpes zoster in primary care","volume":"331","author":"Opstelten","year":"2005","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13555-024-01101-7","article-title":"Herpes Zoster Recurrence: A Narrative Review of the Literature","volume":"14","author":"Parikh","year":"2024","journal-title":"Dermatol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2051013615599151","article-title":"Herpes zoster epidemiology, management, and disease and economic burden in Europe: A multidisciplinary","volume":"3","author":"Johnson","year":"2015","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_28","unstructured":"Nair, P.A., and Patel, B.C. (2024, June 06). Herpes Zoster, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441824\/."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ofu049","DOI":"10.1093\/ofid\/ofu049","article-title":"Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States","volume":"1","author":"Suaya","year":"2014","journal-title":"Open Forum Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.puhe.2018.10.015","article-title":"Systematic review of the evidence on the epidemiology of herpes zoster: Incidence in the general population and specific subpopulations in Spain","volume":"167","author":"Mareque","year":"2019","journal-title":"Public Health"},{"key":"ref_31","first-page":"3","article-title":"Wp\u0142yw immunosupresji na obraz kliniczny p\u00f3\u0142pa\u015bca","volume":"5","author":"Borawski","year":"2018","journal-title":"Neurol. Po Dyplomie"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40257-019-00483-1","article-title":"Herpes Zoster Presentation, Management, and Prevention: A Modern Case-Based Review","volume":"21","author":"Rosamilia","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ced.14650","article-title":"Cigarette smoking and risk of herpes zoster: A population-based cohort study in Taiwan","volume":"46","author":"Dai","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Studahl, M., Petzold, M., and Cassel, T. (2013). Disease burden of herpes zoster in Sweden--predominance in the elderly and in women\u2014A register based study. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-586"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/clinem\/dgab675","article-title":"Association Between Diabetes Mellitus and the Risk of Herpes Zoster: A Systematic Review and Meta-analysis","volume":"107","author":"Huang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12931-022-02305-1","article-title":"Risk factors for herpes zoster: Should people with asthma or COPD be vaccinated?","volume":"24","author":"Safonova","year":"2023","journal-title":"Respir. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s15010-023-02156-y","article-title":"Risk factors for herpes zoster infections: A systematic review and meta-analysis unveiling common trends and heterogeneity patterns","volume":"52","author":"Steinmann","year":"2024","journal-title":"Infection"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/cid\/ciw840","article-title":"Partner Bereavement and Risk of Herpes Zoster: Results from Two Population-Based Case-Control Studies in Denmark and the United Kingdom","volume":"64","author":"Schmidt","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/aje\/kwx338","article-title":"Mood Disorders and Risk of Herpes Zoster in 2 Population-Based Case-Control Studies in Denmark and the United Kingdom","volume":"187","author":"Schmidt","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/S2665-9913(24)00019-5","article-title":"Time to talk to adults with rheumatic diseases about herpes zoster vaccination","volume":"6","author":"Pier","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s13555-021-00535-7","article-title":"Burden of Herpes Zoster in Adult Patients with Underlying Conditions: Analysis of German Claims Data, 2007\u20132018","volume":"11","author":"Batram","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e020528","DOI":"10.1136\/bmjopen-2017-020528","article-title":"Burden of herpes zoster in 16 selected immunocompromised populations in England: A cohort study in the Clinical Practice Research Datalink 2000\u20132012","volume":"8","author":"Yanni","year":"2018","journal-title":"BMJ Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ajd.13534","article-title":"Increased risk of herpes zoster in patients with psoriasis: A longitudinal follow-up study using a national sample cohort","volume":"62","author":"Min","year":"2021","journal-title":"Australas. J. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/1346-8138.15214","article-title":"Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014","volume":"47","author":"Imafuku","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hsieh, W.-C., Chen, C.-H., Cheng, Y.-C., Yu, T.-S., Hsu, C.Y., Ke, D.-S., Lin, C.-M., and Hsu, C.-Y. (2022). The Risk of Herpes Zoster in Women with Polycystic Ovary Syndrome: A Retrospective Population-Based Study. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19053094"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1093\/cid\/ciac549","article-title":"Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine","volume":"76","author":"Parameswaran","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Tung, Y.C., Tu, H.P., Wu, M.K., Kuo, K.L., Su, Y.F., Lu, Y.Y., Lin, C.L., and Wu, C.H. (2020). Higher risk of herpes zoster in stroke patients. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228409"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ke, D.S., Hsu, C.Y., Lin, C.L., Hsu, C.Y., and Kao, C.H. (2020). Herpes zoster in patients with sciatica. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03847-5"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tung, Y.C., Tu, H.P., Tsai, W.C., Chen, C.S., Su, C.H., Shi, H.Y., and Lin, C.L. (2015). Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129043"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5009\/gnl18304","article-title":"Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study","volume":"13","author":"Soh","year":"2019","journal-title":"Gut Liver"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Quiles, C., L\u00f3pez-Lacort, M., D\u00edez-Domingo, J., and Orrico-S\u00e1nchez, A. (2020). Herpes zoster risk and burden of disease in immunocompromised populations: A population-based study using health system integrated databases, 2009\u20132014. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05648-6"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2017.06.010","article-title":"Incidence of herpes zoster amongst adults varies by severity of immunosuppression","volume":"75","author":"Enders","year":"2017","journal-title":"J. Infect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-018-0268-8","article-title":"Burden of Herpes Zoster in the Japanese Population with Immunocompromised\/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005\u20132014","volume":"9","author":"Imafuku","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1080\/21645515.2017.1368600","article-title":"Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009\u20132014","volume":"13","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0961203312470186","article-title":"Increased incidence of herpes zoster among patients with systemic lupus erythematosus","volume":"22","author":"Chakravarty","year":"2013","journal-title":"Lupus"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1093\/rheumatology\/keab538","article-title":"Use of disease-modifying antirheumatic drugs and the subsequent risk of herpes zoster in older adults","volume":"60","author":"Qian","year":"2021","journal-title":"Rheumatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3899\/jrheum.220986","article-title":"Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis in the United States: A Retrospective Cohort Study","volume":"50","author":"Singer","year":"2023","journal-title":"J. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1097\/RHU.0000000000001749","article-title":"The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis","volume":"28","author":"Alves","year":"2022","journal-title":"J. Clin. Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/rheumatology\/kez087","article-title":"A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"TULIP-2 Trial Investigators. Trial of Anifrolumab in Active Systemic Lupus Erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2256047","DOI":"10.1080\/21645515.2023.2256047","article-title":"Hospitalization burden related to herpes zoster infection during the COVID-19 pandemic in Spain (2020\u20132021)","volume":"19","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_64","first-page":"2200390","article-title":"Epidemiology of Herpes Zoster in the pre-vaccination era: Establishing the baseline for vaccination programme\u2019s impact in Spain","volume":"28","author":"Herrador","year":"2023","journal-title":"Euro Surveill."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijid.2021.02.033","article-title":"Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic","volume":"104","author":"Maia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e13930","DOI":"10.1111\/dth.13930","article-title":"Herpes zoster as a potential complication of coronavirus disease 2019","volume":"33","author":"Pona","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41256-020-00155-2","article-title":"Survivors of COVID-19 are at high risk of posttraumatic stress disorder","volume":"5","author":"Xiao","year":"2020","journal-title":"Glob. Health Res. Policy"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s13555-021-00549-1","article-title":"Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review","volume":"11","author":"Parikh","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_69","first-page":"e15521","article-title":"Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination","volume":"35","author":"Almutairi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/ijd.16221","article-title":"Characteristics of herpes zoster infection in patients with COVID-19: A systematic scoping review","volume":"61","author":"Czech","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"ofac118","DOI":"10.1093\/ofid\/ofac118","article-title":"Increased Risk of Herpes Zoster in Adults \u226550 Years Old Diagnosed With COVID-19 in the United States","volume":"9","author":"Bhavsar","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4065\/mcp.2010.0618","article-title":"Herpes zoster recurrences more frequent than previously reported","volume":"86","author":"Yawn","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3346\/jkms.2019.34.e1","article-title":"Recurrence Rate of Herpes Zoster and Its Risk Factors: A Population-based Cohort Study","volume":"34","author":"Kim","year":"2018","journal-title":"J. Korean Med. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"602","DOI":"10.5021\/ad.2017.29.5.602","article-title":"Frequency of Herpes Zoster Recurrence in Central District of Korea","volume":"29","author":"Ha","year":"2017","journal-title":"Ann. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaad.2020.06.1013","article-title":"Risk of recurrent herpes zoster in a population-based cohort study of older adults","volume":"85","author":"Qian","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jinf.2020.12.013","article-title":"Incidence and disease burden of herpes zoster in the population aged \u226550 years in China: Data from an integrated health care network","volume":"82","author":"Sun","year":"2021","journal-title":"J. Infect."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaad.2016.05.037","article-title":"Clinical and immunologic features of recurrent herpes zoster (HZ)","volume":"75","author":"Nakamura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"ofx007","DOI":"10.1093\/ofid\/ofx007","article-title":"Herpes Zoster and Recurrent Herpes Zoster","volume":"4","author":"Shiraki","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13075-022-02871-1","article-title":"Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: A nationwide cohort study","volume":"24","author":"Jeong","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/infdis\/jiz652","article-title":"The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults \u226550 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence","volume":"222","author":"Tseng","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.vaccine.2013.09.018","article-title":"Shingles in Alberta: Before and after publicly funded varicella vaccination","volume":"32","author":"Russell","year":"2014","journal-title":"Vaccine"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1136\/bmj.p2497","article-title":"Long term effectiveness of live herpes zoster vaccine","volume":"383","author":"Mbinta","year":"2023","journal-title":"BMJ"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Marra, Y., and Lalji, F. (2022). Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines. Viruses, 14.","DOI":"10.3390\/v14122667"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40121-024-01002-4","article-title":"The Incidence of Herpes Zoster Complications: A Systematic Literature Review","volume":"13","author":"Giannelos","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.vaccine.2024.02.022","article-title":"Hospitalizations of patients with herpes zoster in Poland during 2012\u20132021: A population-based study","volume":"42","author":"Kanecki","year":"2024","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: Burden of disease in France","volume":"28","author":"Sarazin","year":"2010","journal-title":"Vaccine"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Rojas, A., Gil-Prieto, R., N\u00fa\u00f1ez-Gallo, D.\u00c1., Matute-Cruz, P., and Gil-de-Miguel, A. (2017). Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005\u20132014). BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2688-y"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/ijerph6092344","article-title":"Herpes Zoster Associated Hospital Admissions in Italy: Review of the Hospital Discharge Forms","volume":"6","author":"Gabutti","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J. Infect."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40121-022-00717-6","article-title":"Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016\u20132019)","volume":"12","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"ref_91","first-page":"1","article-title":"Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm. Rep."},{"key":"ref_92","unstructured":"(2025, January 06). Shingrix Product Monograph. Available online: https:\/\/ca.gsk.com\/media\/6259\/shingrix-pm-en.pdf."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/3\/71\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:42:51Z","timestamp":1760028171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/3\/71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":92,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["diseases13030071"],"URL":"https:\/\/doi.org\/10.3390\/diseases13030071","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}